Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update

JW Mouton, MN Dudley, O Cars… - Journal of …, 2005 - academic.oup.com
Interest in the relationships between the pharmacokinetics (PK) and pharmacodynamics
(PD) of antimicrobial agents has increased over recent years. Since the appearance 2 years …

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

F Pea, P Viale, F Pavan, M Furlanut - Clinical pharmacokinetics, 2007 - Springer
Continuous renal replacement therapy (CRRT), particularly continuous venovenous
haemofiltration (CVVH) and continuous venovenous haemodiafiltration (CVVHDF), are …

Breaking down the breakpoints: rationale for the 2022 Clinical and Laboratory Standards Institute revised piperacillin-tazobactam breakpoints against …

PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
Piperacillin-tazobactam (PTZ) is one of the most common antibiotics administered to
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …

Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

CM Perry, A Markham - Drugs, 1999 - Springer
Piperacillin/tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad
spectrum of antibacterial activity encompassing most Gram-positive and Gram-negative …

Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects

G Chandorkar, JA Huntington… - Journal of …, 2012 - academic.oup.com
Objectives Appropriate antibiotic exposure at the site of infection is important for clinically
effective therapy. This study compared the epithelial lining fluid (ELF) penetration of …

Piperacillin–tazobactam: a β-lactam/β-lactamase inhibitor combination

A Gin, L Dilay, JA Karlowsky, A Walkty… - Expert review of anti …, 2007 - Taylor & Francis
Piperacillin–tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad
spectrum of antibacterial activity that includes Gram-positive and-negative aerobic and …

Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection

L Hill, N Veli, PJ Coote - International journal of antimicrobial agents, 2014 - Elsevier
The aim of this study was to determine whether Galleria mellonella larvae can be used (i) as
an in vivo infection model for Pseudomonas aeruginosa and (ii) for evaluating the …

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy

M Ulldemolins, S Vaquer, M Llauradó-Serra, C Pontes… - Critical care, 2014 - Springer
Although early and appropriate antibiotic therapy remains the most important intervention for
successful treatment of septic shock, data guiding optimization of beta-lactam prescription in …

Antimicrobial breakpoints for Gram-negative aerobic bacteria based on pharmacokinetic–pharmacodynamic models with Monte Carlo simulation

CR Frei, NP Wiederhold… - Journal of antimicrobial …, 2008 - academic.oup.com
Objectives This study describes a comprehensive programme designed to develop
pharmacokinetic–pharmacodynamic (PK–PD) breakpoints for numerous antimicrobial …

Antibiotic dosing in critically ill patients with acute kidney injury

RF Eyler, BA Mueller - Nature Reviews Nephrology, 2011 - nature.com
A common cause of acute kidney injury (AKI) is sepsis, which makes appropriate dosing of
antibiotics in these patients essential. Drug dosing in critically ill patients with AKI, however …